Skip to main content

Table 5 Prednisolone treatment in PMR

From: Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with Polymyalgia Rheumatica: a narrative review

Treatment duration

Prednisolone dosage (mg)

First 2–4 weeks

15

Next 2–4 weeks

12.5

Next 4 weeks

10

Next 4 weeks

8.75 (e.g. 10 and 7.5 alternate days)

Next 4 weeks

7.5

Next 4 weeks

6.25

Next 4 weeks

5

Next 4 weeks

3.75

Next 4 weeks

2.5

Next 4 weeks

1.25

Discontinuation

0

Relapse

Increase prednisolone to the pre-relapse dose and taper gradually (within 4–8 weeks) to the dose at which the relapse occurred.

Consider methotrexate

In patients with comorbidities that may be exacerbated by GC therapy and in patients with relapsing disease or GC-related adverse events.